Aclarion waves off investor’s acquisition offer
Frustration with med-device firm’s board, stock price led to unsolicited bid
Leaders of Aclarion Inc. on Monday rejected an unsolicited takeover bid from an investor who has lambasted the Broomfield-based healthcare technology firm’s board over its failure to maintain shareholder value.
THIS ARTICLE IS FOR SUBSCRIBERS ONLY
Continue reading for less than $3 per week!
Get a month of award-winning local business news, trends and insights
Access award-winning content today!
Related Posts
-
BROOMFIELD — Aclarion Inc. (Nasdaq: ACON) is appealing its latest delisting notice from Nasdaq. The…
-
A New York-based hospitality real estate investor recently bought the Residence Inn and Fairfield Inn…
-
Advisory firm urges shareholders approval BOULDER — Investment firm Tikvah Management LLC plans to oppose…
-
BOULDER — Enliven Therapeutics Inc. (Nasdaq: ELVN), a Boulder-based oncology drug developer, has filed a…
